RDT

Serial Number 76150751
606

Registration Progress

Application Filed
Oct 20, 2000
Under Examination
Jan 14, 2003
Approved for Publication
Oct 2, 2002
Published for Opposition
Oct 22, 2002
Registered

Trademark Image

RDT

Basic Information

Serial Number
76150751
Filing Date
October 20, 2000
Published for Opposition
October 22, 2002
Abandonment Date
July 15, 2003
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 15, 2003
Classes
005

Rights Holder

ALLERGAN, INC.

03
Address
2525 DUPONT DRIVE
IRVINE, CA 92612

Ownership History

Oculex Pharmaceuticals, Inc.

Original Applicant
03
Sunnyvale, CA

Oculex Pharmaceuticals, Inc.

Owner at Publication
03
Sunnyvale, CA

ALLERGAN, INC.

New Owner After Publication #1
03
IRVINE, CA

Legal Representation

Attorney
SALLY M ABEL

USPTO Deadlines

All Deadlines Cleared

All 4 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

17 events
Date Code Type Description Documents
Sep 25, 2003 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jan 14, 2003 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 23, 2002 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 22, 2002 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 17, 2002 MAIL I PAPER RECEIVED Loading...
Oct 2, 2002 NPUB O NOTICE OF PUBLICATION Loading...
Sep 30, 2002 MAIL I PAPER RECEIVED Loading...
Sep 5, 2002 MAIL I PAPER RECEIVED Loading...
Aug 1, 2002 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 22, 2002 EXPI T EX PARTE APPEAL-INSTITUTED Loading...
Jul 22, 2002 JURT T JURISDICTION RESTORED TO EXAMINING ATTORNEY Loading...
Jun 26, 2002 EXAF T EXPARTE APPEAL RECEIVED AT TTAB Loading...
Jun 14, 2002 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 11, 2001 CNFR O FINAL REFUSAL MAILED Loading...
Aug 31, 2001 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 28, 2001 CNRT F NON-FINAL ACTION MAILED Loading...
Feb 23, 2001 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
Drug-containing delivery devices, namely, sustained release ocular implants sold pre-filled with medication for use in the eyes
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005